Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases
- PMID: 31596875
- PMCID: PMC6785117
- DOI: 10.1371/journal.pone.0223246
Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases
Abstract
Background: Previous studies of radiological damage in rheumatoid arthritis (RA) have used candidate-gene approaches, or evaluated single genome-wide association studies (GWAS). We undertook the first meta-analysis of GWAS of RA radiological damage to: (1) identify novel genetic loci for this trait; and (2) test previously validated variants.
Methods: Seven GWAS (2,775 RA cases, of a range of ancestries) were combined in a meta-analysis. Radiological damage was assessed using modified Larsen scores, Sharp van Der Heijde scores, and erosive status. Single nucleotide polymophsim (SNP) associations with radiological damage were tested at a single time-point using regression models. Primary analyses included age and disease duration as covariates. Secondary analyses also included rheumatoid factor (RF). Meta-analyses were undertaken in trans-ethnic and European-only cases.
Results: In the trans-ethnic primary meta-analysis, one SNP (rs112112734) in close proximity to HLA-DRB1, and strong linkage disequilibrium with the shared-epitope, attained genome-wide significance (P = 4.2x10-8). In the secondary analysis (adjusting for RF) the association was less significant (P = 1.7x10-6). In both trans-ethnic primary and secondary meta-analyses 14 regions contained SNPs with associations reaching P<5x10-6; in the European primary and secondary analyses 13 and 10 regions contained SNPs reaching P<5x10-6, respectively. Of the previously validated SNPs for radiological progression, only rs660895 (tagging HLA-DRB1*04:01) attained significance (P = 1.6x10-5) and had a consistent direction of effect across GWAS.
Conclusions: Our meta-analysis confirms the known association between the HLA-DRB1 shared epitope and RA radiological damage. The lack of replication of previously validated non-HLA markers highlights a requirement for further research to deliver clinically-useful prognostic genetic markers.
Conflict of interest statement
NAS has received less than $10,000 consultancies from Bristol myers squibb, and research grants from Mallinchrodt Pharmaceuticals and BWH (which is sponsored by Amgen, BMS, Sanofi/Regeneron, Dxterit, Crescendo and UCB). MEW has received less than $10,000 consultancies from Abbvie, Amgen, Novartis, Roche, Glaxo Smith Kline, Merck, Samsung, Crescendo Bioscience, Gilead, Pfizer and UCB, and over $10,000 from Lilly, and BMS. The BRASS study receives funding from Bristol myers squibb, Sanofi/Regeneron, AMGEN, and Crescendo Biosciences. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures


Similar articles
-
Caucasian and Asian specific rheumatoid arthritis risk loci reveal limited replication and apparent allelic heterogeneity in north Indians.PLoS One. 2012;7(2):e31584. doi: 10.1371/journal.pone.0031584. Epub 2012 Feb 15. PLoS One. 2012. PMID: 22355377 Free PMC article.
-
A Multinational Arab Genome-Wide Association Study Identifies New Genetic Associations for Rheumatoid Arthritis.Arthritis Rheumatol. 2017 May;69(5):976-985. doi: 10.1002/art.40051. Epub 2017 Mar 31. Arthritis Rheumatol. 2017. PMID: 28118524
-
Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis?J Rheumatol. 2015 Jul;42(7):1131-40. doi: 10.3899/jrheum.141211. Epub 2015 May 15. J Rheumatol. 2015. PMID: 25979711 Free PMC article. Clinical Trial.
-
Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population.Arthritis Res Ther. 2015 Apr 18;17(1):104. doi: 10.1186/s13075-015-0623-4. Arthritis Res Ther. 2015. PMID: 25927497 Free PMC article. Review.
-
Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis.Rheumatology (Oxford). 2008 Dec;47(12):1768-70. doi: 10.1093/rheumatology/ken374. Epub 2008 Oct 4. Rheumatology (Oxford). 2008. PMID: 18838388 Review.
Cited by
-
Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response.Int J Mol Sci. 2020 Jul 11;21(14):4911. doi: 10.3390/ijms21144911. Int J Mol Sci. 2020. PMID: 32664585 Free PMC article. Review.
-
Current Understanding of an Emerging Role of HLA-DRB1 Gene in Rheumatoid Arthritis-From Research to Clinical Practice.Cells. 2020 May 2;9(5):1127. doi: 10.3390/cells9051127. Cells. 2020. PMID: 32370106 Free PMC article. Review.
-
Association of AFF3 Gene Polymorphism rs10865035 with Rheumatoid Arthritis: A Population-Based Case-Control Study on a Pakistani Cohort.Genet Res (Camb). 2021 May 15;2021:5544198. doi: 10.1155/2021/5544198. eCollection 2021. Genet Res (Camb). 2021. PMID: 34104118 Free PMC article.
-
Polygenic risk scores of rheumatoid arthritis associated with seropositivity and bone erosions in a Taiwanese population.Sci Rep. 2025 Jul 16;15(1):25700. doi: 10.1038/s41598-025-08254-1. Sci Rep. 2025. PMID: 40670424 Free PMC article.
-
A genome-wide association study identifying the SNPs predictive of rapid joint destruction in patients with rheumatoid arthritis.Biomed Rep. 2021 Mar;14(3):31. doi: 10.3892/br.2021.1407. Epub 2021 Jan 29. Biomed Rep. 2021. PMID: 33585033 Free PMC article.
References
-
- Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum. 2002;31: 355–360. - PubMed
-
- Balsa A, Cabezon A, Orozco G, Cobo T, Miranda-Carus E, Lopez-Nevot MA, et al. Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor. Arthritis Res Ther. 2010;12: R62 10.1186/ar2975 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- U19 GM061388/GM/NIGMS NIH HHS/United States
- 36661 /VAC_/Versus Arthritis/United Kingdom
- MR/K006584/1/MRC_/Medical Research Council/United Kingdom
- 18387 /VAC_/Versus Arthritis/United Kingdom
- MR/M501633/2/MRC_/Medical Research Council/United Kingdom
- CRUK_/Cancer Research UK/United Kingdom
- G1001516/MRC_/Medical Research Council/United Kingdom
- BHF_/British Heart Foundation/United Kingdom
- MR/K015346/1/MRC_/Medical Research Council/United Kingdom
- RP-PG-0407-10314/DH_/Department of Health/United Kingdom
- 20011/VAC_/Versus Arthritis/United Kingdom
- 19739 /VAC_/Versus Arthritis/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- 18475 /VAC_/Versus Arthritis/United Kingdom
- CSO_/Chief Scientist Office/United Kingdom
- 05/40/04/DH_/Department of Health/United Kingdom
- MC_PC_13041/MRC_/Medical Research Council/United Kingdom
- G0902393/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Research Materials